Pharmaceutical giant Johnson & Johnson is investing $55 billion over four years to boost its capacity in the United States, bolstering its presence in the domestic market. This significant investment will enable the company to enhance its manufacturing capabilities and meet growing demand for its pharmaceutical products in the country.
Source: https://endpts.com/johnson-johnson-earmarks-55b-to-boost-us-capacity